VC  BioAdvance

     Office Locations:

3711 Market Street, 8th Floor
Philadelphia, PA 19104
Phone: 610-230-0544

Get all office locations for this firm with a National Database subscription.


  • Early
  • Seed



  • Life Sciences & Healthcare
  • Medical Device



    BioAdvance provides funding to startup life sciences companies in Southeastern Pennsylvania through its $20 million Greenhouse Fund. The Greenhouse Program invests up to $1.25 million in seed-stage companies over the life of an investment. Initial seed investments are up to $500,000 and BioAdvance also provides its funding recipients with business assistance and critical resources as they grow. The program also invests up to $50,000 in pre-seed investments.The firm invests in therapeutics, devices, diagnostics and platform technologies focused on human health. Since its first investments in 2003, BioAdvance has become one of the nation's leading investors providing pre-seed and seed-stage funding. To date, the firm has committed $24.1 million to 35 seed-stage companies and 21 pre-seed investments. BioAdvances portfolio companies are working to develop products to treat health problems including Alzheimer's disease, cancer, obesity, GI disorders, neurological and respiratory illnesses. BioAdvance investments have enabled its portfolio companies to leverage more than $1.6 billion in subsequent capital into the region (from private equity, grants, collaborations and M&A activity).

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Barbara S. Schilberg Managing Director and Chief Executive Officer
    Gregory Harriman Venture Partner
    Marnie McCoy Program Director
    Robert Driscoll Director of Finance
    Shahram Hejazi Venture Partner


    Portfolio companies include:

      Avid Radiopharmaceuticals
        web link

      Bainbridge Halth
        web link

      BioBots, Inc.
        web link

      BioDetego, LLC
        web link

      CarePartners Plus, LLC.
        web link

        web link

      Cohero Health
        web link

        web link

      Eagle Vision Pharmaceutical
        web link

      Enzium, Inc.
        web link

        web link

      Galleon Pharmaceuticals
        web link

      Genome Profiling, LLC
        web link

      Group K Diagnostics
        web link

      Halo Labs
        web link

      Hsiri Therapeutics, LLC
        web link

      Imiplex, LLC
        web link

        web link

      Immunome, Inc.
        web link

        web link

      Innovative Supply Solutions
        web link

      Intezyne, Inc.
        web link

      Jenrin Discovery
        web link

      Keriton, LLC.
        web link

        web link

      Marillion Pharmaceuticals
        web link

      Mebias Discovery
        web link

      Melior Discovery
        web link

      Merganser Biotech
        web link

      Midway Pharmaceuticals
        web link

      Niiki Pharma
        web link

      Novira Therapeutics
        web link

        web link

      Oncora Medical
        web link

        web link

      Ossianix, Inc.
        web link

      Palvella Therapeutics

        web link

      Phoenix S&T
        web link

      QR Pharma
        web link

      Relmada Therapeutics
        web link

      RMH Sciences
        web link

      The One Health Company
        web link

        web link

        web link

        web link


    Recent News:

      There is no recent news for BioAdvance.